Biopharmaceutical company, Ocular Therapeutix, Inc. (OCUL), Thursday announced the pricing of an underwritten public offering of 30.8 million shares at $3.25 per share, to raise $100.1 million.
from RTT - Before the Bell https://ift.tt/sfVIneh
via IFTTT
No comments:
Post a Comment